Immunisation with either high-dose or low-dose DENVax formulations induced neutralising antibody responses to all four dengue virus serotypes ; 30 days after the second dose , 47 ( 62 % ) of 76 participants given vaccine seroconverted to all four serotypes and 73 ( 96 % ) participants seroconverted to three or more dengue viruses .